Biomedical devices

US9285508B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9285508-B2
Application numberUS-45642309-A
CountryUS
Kind codeB2
Filing dateJun 16, 2009
Priority dateJun 16, 2009
Publication dateMar 15, 2016
Grant dateMar 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biomedical devices such as contact lenses formed from a polymerization product of a mixture comprising (a) a multi-armed macromonomer comprising multiple side chains attached to a nucleus, wherein each side chain comprises a thio carbonyl thio fragment of the same or different reversible addition fragmentation chain transfer (“RAFT”) agent; and (b) one or more biomedical device-forming monomers are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A biomedical device comprising an in-mold polymerization product of a mixture comprising (a) a multi-armed macromonomer block copolymer comprising multiple side chains attached to a nucleus, wherein each side chain is a block copolymer comprising a thio carbonyl thio fragment of the same or different reversible addition fragmentation chain transfer (RAFT) agent, and one or more hydrophilic units, and further wherein each side chain does not contain one or more hydrophobic units; and (b) one or more biomedical device-forming monomers, wherein the biomedical device is a contact lens, an intraocular lens or a conical implant. 2. The biomedical device of claim 1 , wherein the thio carbonyl thio fragment of each side chain is the same thio carbonyl thio fragment. 3. The biomedical device of claim 1 , wherein the thio carbonyl thio fragment of each side chain comprises a dithioester group, xanthate group, dithiocarbamate group or trithiocarbonate group. 4. The biomedical device of claim 1 , wherein the multi-armed macromonomer comprises 3 or more side chains. 5. The biomedical device of claim 1 , wherein the multi-armed macromonomer comprises 3 to 1.0 side chains. 6. The biomedical device of claim 1 , wherein the hydrophilic units are derived from a hydrophilic monomer selected from the group consisting of an unsaturated carboxylic acid, acrylamide, vinyl lactam, poly(alkyleneoxy)(meth)acrylate, (meth)acrylic acid, hydroxy-containing-(meth)acrylate, hydrophilic vinyl carbonate, hydrophilic vinyl carbamate monomer, hydrophilic oxazolone monomer, and mixtures thereof. 7. The biomedical device of claim 1 , wherein the hydrophilic units are derived from a hydrophilic monomer selected from the group consisting of methacrylic acid, acrylic acid, 2-hydroxyethylmethacrylate, 2-hydroxyethylacrylate, N-vinyl pyrrolidone, methacrylamide, N,N-dimethylacrylamide, ethylene glycol dimethacrylate and mixtures thereof. 8. The biomedical device of claim 1 , wherein the hydrophilic units are derived from an ethylenically unsaturated polymerizable alkoxylated polymer selected from the group consisting of polyethylene glycol (PEG)-200 methacrylate, PEG-400 methacrylate, PEG-600 methacrylate, PEG 1000 methacrylate and mixtures thereof. 9. The biomedical device of claim 1 , wherein the hydrophilic units comprise about 100 to about 1000 units. 10. The biomedical device of claim 1 , wherein the nucleus comprises a substituted or unsubstituted cyclic or polycyclic containing group. 11. The biomedical device of claim 1 , wherein the nucleus comprises one or more oxyalkylene units or an alkylene group. 12. The biomedical device of claim 1 , wherein the one or more biomedical device-forming monomers is a silicone-containing monomer. 13. The biomedical device of claim 1 , wherein the one or more biomedical device-forming monomers is a hydrophilic monomer or hydrophobic monomer. 14. The biomedical device of claim 1 , wherein the mixture further comprises a hydrophilic monomer, hydrophobic monomer or both. 15. The biomedical device of claim 1 , wherein the contact lens is a rigid gas permeable contact lens. 16. The biomedical device of claim 1 wherein the contact lens is a soft contact lens. 17. The biomedical device of claim 1 wherein the contact lens is a hydrogel contact lens. 18. A biomedical device obtained by casting a mixture comprising (a) a multi-armed macromonomer block copolymer comprising multiple side chains attached to a nucleus, wherein each side chain is a block copolymer comprising a thio carbonyl thio fragment of the same or different reversible addition fragmentation chain transfer (RAFT) agent, and one or more hydrophilic units, and further wherein each side chain does not contain one or more hydrophobic units; and (b) one or more biomedical device-forming monomers, into a biomedical device by mold polymerization, wherein the biomedical device is a contact lens, an intraocular lens or a corneal implant.

Assignees

Inventors

Classifications

  • Hydrogels or hydrocolloids · CPC title

  • Hydrogels or hydrocolloids · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • G02B1/043Primary

    Contact lenses · CPC title

  • obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9285508B2 cover?
Biomedical devices such as contact lenses formed from a polymerization product of a mixture comprising (a) a multi-armed macromonomer comprising multiple side chains attached to a nucleus, wherein each side chain comprises a thio carbonyl thio fragment of the same or different reversible addition fragmentation chain transfer (“RAFT”) agent; and (b) one or more biomedical device-forming monomers…
Who is the assignee on this patent?
Nunez Ivan M, Kunzler Jay F, Linhardt Jeffrey G, and 2 more
What technology area does this patent fall under?
Primary CPC classification G02B1/043. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).